beta
Trial Radar IA
Lo studio clinico NCT07488585 (THYMAL 01) per Noduli tiroidei, Thyroid Abnormalities è non ancora in arruolamento. Consulti la vista a schede del Radar degli Studi Clinici e gli strumenti di scoperta IA per tutti i dettagli. Oppure, ponga pure una domanda qui.
Un studio corrisponde ai criteri del filtro
Vista a schede

This Study Tests a New Sound Blade Ultrasound for Thyroid Scans. It Compares Its Images With Regular Hospital Ultrasounds to See Which is Clearer. The Images Will Help Build Future AI Tools to Improve Care. (THYMAL 01) 30

Non ancora in arruolamento
I dettagli dello studio clinico sono disponibili principalmente in inglese. Tuttavia, Trial Radar IA può essere d'aiuto! Basta cliccare su 'Spiega lo studio' per visualizzare e discutere le informazioni sullo studio nella lingua selezionata.
La sperimentazione clinica NCT07488585 (THYMAL 01) è uno studio interventistico per Noduli tiroidei, Thyroid Abnormalities, attualmente non ancora in arruolamento. L'arruolamento dovrebbe iniziare il 31 maggio 2026, con l'obiettivo di raggiungere 30 partecipanti. Sotto la guida di Sound Blade Medical Inc., dovrebbe concludersi entro il 1 settembre 2027. I dati più recenti da ClinicalTrials.gov sono stati aggiornati l'ultima volta il 23 marzo 2026.
Sommario breve
This study is testing a new type of ultrasound made just for looking at the thyroid, a small gland in the neck. During one clinic visit, people will have two safe and painless scans: the regular ultrasound they would normally get, and a second scan using the research device. Both scans use a probe on the skin with gel-there are no needles, no radiation, and no changes to their medical care. The goal is to see if the ...Mostra di più
Descrizione dettagliata
Our purpose-built thyroid US platform, integrated with state-of-the-art machine-learning algorithms, will achieve accurate detection and delineation of thyroid nodules and neighboring critical structures, and will produce a trackable three-dimensional nodule model capable of guiding minimally invasive ablation while providing real-time volumetric quantification of treatment progress and residual disease.

STUDY DESIG...

Mostra di più
Titolo ufficiale

A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning: A Pilot Study

Patologie
Noduli tiroideiThyroid Abnormalities
Altri ID dello studio
  • THYMAL 01
Numero NCT
Data di inizio (effettiva)
2026-05-31
Ultimo aggiornamento pubblicato
2026-03-23
Data di completamento (stimata)
2027-09
Arruolamento (previsto)
30
Tipo di studio
Interventistico
FASE
N.D.
Stato
Non ancora in arruolamento
Parole chiave
Thyroid Nodule
Scopo principale
Diagnostico
Allocazione
N.D.
Modello di intervento
A gruppo singolo
Mascheramento
Nessuno (studio in aperto)
Bracci / Interventi
Gruppo/Braccio di partecipantiIntervento/Trattamento
SperimentaleParticipants who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound after signing consent will undergo a second ultrasound using the Sound Blade Ultrasound. It will be done at the same visit, right after the SOC ultrasound is complete.
Thyroid ultrasound
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound after signing consent will undergo a second ultrasound using the Sound Blade Ultrasound. It will be done at the same visit, right after the SOC ultrasound is complete.
Esito primario
Misure di esitoDescrizione della misuraArco temporale
Part A: Prospective Thyroid Imaging Study Objective: Visualization and Image Quality Assessment of Key Neck Structures Using Ultrasound Visibility Scale and Radiologist Comparison Form
1 Visibility Scale (Primary Component) Independent, blinded radiologists will rate the visibility of each structure using a 3-point scale: 0 = Not Visible (structure cannot be identified) 1. = Partially Visible (structure identifiable but with limited definition) 2. = Fully Visible (structure clearly identified with complete anatomic definition) Scores from each reviewer will be averaged for analysis. 2. Radiologist Comparative Image Quality Form (Secondary of Primary Outcome) Radiologists will complete a structured comparison form evaluating: Size (agreement between devices; measured in mm) Margins (sharp, indistinct, irregular) Edge Definition (well-defined vs. poorly defined) Overall Visibility (device-to-device comparison: better, worse, equivalent) These assessments will be recorded for each thyroid nodule and relevant neck structure. The primary endpoint is the difference in mean visibility scores and qualitative image quality ratings between the investigational and SOC ultrasound
This will take place at month 3 to end of month 7 of study.
Part B: Machine Learning Model Development Objective Develop and internally evaluate a machine-learning model that identifies and segments thyroid nodules and predefined neck structures (carotid, jugular, vagus nerve, trachea, thyroid nodule) on image
Outcome Measure 1: Segmentation Accuracy Performance of the machine-learning model in segmenting thyroid nodules and neck structures (carotid artery, internal jugular vein, vagus nerve, trachea). Accuracy will be evaluated using overlap-based metrics, including the Dice Similarity Coefficient and Intersection-over-Union (IoU). These unitless measures quantify agreement between the model-generated segmentation and expert-annotated reference masks. Outcome Measure 2: Visibility and Detection Performance Performance of the model in identifying the presence or absence of thyroid nodules and key neck structures on ultrasound images. Detection quality will be assessed using standard classification metrics, including sensitivity, specificity, positive predictive value, negative predictive value, and area under the ROC curve (AUC). These metrics quantify diagnostic accuracy. Outcome Measure 3: 3-D Reconstruction and Focus-Tracking Feasibility Feasibility of generating consistent 3-D thyroid
At month 4 until then end of the study, month 12.
Assistente alla partecipazione
Criteri di eleggibilità

Età idonea
Adulto, Adulto anziano
Età minima
18 Years
Sessi idonei
Tutti
  • Participants must be ≥ 18 years of age
  • Competent to sign informed consent
  • Known thyroid nodule demonstrated on a prior thyroid US and is undergoing active surveillance of the nodule with serial USs

  • Unable to lay flat for 15 minutes
  • Active neck wounds, dressings, or skin conditions that would interfere with neck US (e.g., preclude transducer placement)
  • Cervical spine or back disease that would prevent neck extension and would hinder the ability to obtain accurate thyroid US images
  • Previous thyroid surgeries, radiation of face and neck
  • Known inflammatory thyroid diseases or thyroiditis (e.g., Graves, Hashimoto)
Sound Blade Medical Inc. logoSound Blade Medical Inc.
Contatti principali dello studio
Contatto: Deborah Wright, Project Manager, RN, 902-225-6835, [email protected]
Contatto: Richard Balys, MD, MD, 902-223-8032, [email protected]
Nessun dato sulle località